Tang Capital Management, based in California, backs life sciences companies at Series A and Series B stages, acting as a specialist investor.
1 person on the investing team, 1 of them partners who can make the call. Partners are listed first.
Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Tang Capital Management reports entry at series a, series b.
Tang Capital Management has not reported a check size.
Tang Capital Management has not reported a lead preference.
Kevin Tang (Founder & Manager).
No recent activity since September 2026.
Work at Tang Capital Management? Claim or correct this profile.